• Reverse Distributor

    Pharmacists, Here Are 10 Ways To Maximize Your Expired Return Credits

    Pharmacists, Here Are 10 Ways To Maximize Your Expired Return Credits…   Every day at United Rx Solutions, we see many Non-Returnable items that could have been Returnable for credit with just a little due diligence. Here are some simple ways you can save your facility thousands of dollars per…

    Read More
    0 755
  • Biosimilar Drugs : 10 Things You Need to Know About Them

    Are you planning to invest in pharmaceutical products? You’ll find a great opportunity with biosimilar, one of the two types of biological products on the market. The Biologics Price Competition and Innovation Act (BPCI Act) provided an abbreviated licensure pathway for biological products to be demonstrated as biosimilar or highly…

    Read More
    0 370
  • Concerns and Opportunities in Biosimilar Drugs

    There are growing opportunities in biosimilar drugs today, especially because patents for biologic agents that first came out of the market in the 1980s are beginning to expire. This opens doors for agents of non-proprietary versions of biologics to enter the market. Along with these opportunities, however, are concerns related…

    Read More
    0 559
  • Biosimilars versus Generics: Understanding the Difference

    Medicines these days come from a variety of sources. Some are developed using natural substances, such as plant extracts, while others are produced in a laboratory using a mixture of different chemicals. Some of the most important medications, however, are biological. That is, they are made from living organisms. These…

    Read More
    0 1202
  • Cost Savings Biosimilar Drugs

    It is projected that, in the future, 20% of GDP will come from health care, taking into account the current rate of expenditure. Part of that expensive health care cost is the use of biologic products. These are the most costly medications anyone can find. Their price can range from…

    Read More
    0 522
  • The Purple Book

    The US Food and Drug Administration (FDA) published the first edition of the Purple Book on September 9, 2014. It is formally known as the Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations. It was published several years after the Biologics Price Competition and…

    Read More
    0 393
  • Top 25 Biosimilar Drug Manufacturers

    The market for biosimilar drugs has vast potential, with future growth foreseen to move at a rapid pace. And based on reports from biosimilar drug manufacturers worldwide, with consideration on products, market shares, sales results, and R&D, biosimilar medicines have a bright outlook, starting from 2015 to 2025. A report…

    Read More
    0 685
  • What Are Biosimilar Drugs?

    Biologics is popularly associated with their potential to fight cancer, which would have been great news for cancer patients if not for their high price tag. But under the Biologics Price Competition and Innovation Act (BPCI Act) of the Obamacare, FDA can now approve the development of biosimilars. Pharmaceutical companies…

    Read More
    0 281
  • History of Ketamine

    Ketamine, known as Special K on the streets, has become a surprise weapon in the war against depression. Pharmaceutical companies are racing to develop drugs that improve upon it, or can be paired with it. NeuroRx has made progress with its drug, Cyclurad which, when paired with ketamine, has the potential to…

    Read More
    1 1084
  • 5 Facts to Know About Compounding Pharmacies

    5 Facts to Know About Compounding Pharmacies Two questions need to be addressed here: what is compounding and what is a compounding pharmacy? This can be explained through a scenario: Suppose a patient needs medication, but it has been discontinued. Through compounding (done by a licensed pharmacist), the patient can…

    Read More
    3 1301